Page 23 - இபோ நிறுவனம் க்கு பொருளாதார ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jan 20, 2021 MUNICH – A storm is raging over the European Union’s failure to have ordered more of the approved COVID-19 vaccines ahead of time. Stephane Bancel, the CEO of the U.S. pharmaceutical company Moderna, which gained approval for its vaccine shortly after Pfizer/BioNTech, claims that the EU has relied too much on “vaccines from its own laboratories.” Did the European Commission prioritize supporting its own pharmaceutical industry over protecting human lives? In fact, matters aren’t so simple. Contrary to what Bancel wants us to believe, the EU has actually ordered too little of its own vaccine. After all, the vaccine that is being administered most widely across the West was developed by a German company, BioNTech, and thus comes from the EU (though it was tested and partly produced in partnership with Pfizer in the United States and with Fosun Pharma in China).

United statesUnited kingdomStephane bancelHans werner sinnFosun pharmaIfo institute for economic researchEuropean commissionTreaty on european unionEuropean unionUniversity of munichAdvisory councilSubsidiarity principleWerner sinnIfo instituteEconomic researchEuro trap